Products

Our Pipeline

Polygen generic product pipeline represents a comprehensive focus across multiple therapeutic areas and dosage forms. Polygen’s generic pipeline consists of different products in various stages of development, filed and awaiting U.S. FDA approval.

Polygen product pipeline covers broad therapeutic areas including Antihyperlipidemic, Alzheimer’s dementia, Anorectic, Estrogen receptor modulator, Skeletal Muscle Relaxant, anti-epileptic and Antispasmodic 

Product         Status Anticipated Filing
A Under review at FDA       ANDA filed
B Under review at FDA       ANDA filed
C Development & Scale up Complete  Second Quarter 2017
D Development & Scale up Complete Second Quarter 2017
E Development & Scale up Complete Second Quarter 2017
F Under Development Third Quarter 2017
G Under Development Third Quarter 2017
H Under Development Third Quarter 2017

ANDA Approved Products

ANDA 207821 Amlodipine Besylate Tablets (2.5, 5.0 & 10mg)

ANDA 206342 Phentermine Hydrochloride Tablets (37.5 mg)

41-17 Mercedes Way
Edgewood, NY 11717
Phone: 631-392-4044
631-392-4045
Fax: 631-392-4046
Email: info@polygenpharma.com
Valid XHTML 1.0 Transitional
Valid CSS!